Liraglutide 70377-0095-52

Package NDC

70377-0095-52

Manufacturer: Biocon Pharma Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: March 27, 2026
Listing Expires: December 31, 2027
Application: ANDA217063

Need to source Liraglutide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Liraglutide	6 mg/mL

Drug Class

GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]

Selected Package

70377-0095-52Selected

3 SYRINGE, PLASTIC in 1 CARTON (70377-095-52) / 3 mL in 1 SYRINGE, PLASTIC

Other packages for this product(1)

70377-0095-53

5 SYRINGE, PLASTIC in 1 CARTON (70377-095-53) / 3 mL in 1 SYRINGE, PLASTIC

View →